tiprankstipranks
Trending News
More News >
Manulife Financial Corp (TSE:MFC)
TSX:MFC

Manulife Financial (MFC) AI Stock Analysis

Compare
2,101 Followers

Top Page

TSE:MFC

Manulife Financial

(TSX:MFC)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
C$55.00
â–²(13.24% Upside)
Action:DowngradedDate:02/18/26
The score is driven primarily by solid financial recovery and a generally well-managed balance sheet, supported by reasonable valuation and constructive earnings-call updates (growth and an accretive acquisition). The main offsets are softer near-term technical momentum and operational risks flagged on the call (U.S. mortality and credit-loss pressures), plus signs of margin slippage in 2025.
Positive Factors
Diversified, high-growth premium sales and Asia strength
Manulife’s core insurance sales show durable momentum: APE +15% overall and Asia APE +31%, with new business CSM and value rising sharply. Persistent high sales in Asia and diversified product mix support recurring premium flows and structural revenue growth over the next several years.
Strong capital position and controlled leverage
A LICAT ratio of ~136% and leverage ~23.6% provide a durable cushion for underwriting and growth initiatives. This capital strength supports risk-taking (e.g., private markets), dividend policy consistency, and the ability to absorb shocks without materially impairing long-term strategic plans or regulatory standing.
Strategic private credit acquisition expands fee and yield profile
Buying a 75% stake in Comvest materially expands Manulife’s private credit platform, broadening fee-bearing AUM and access to higher-yielding assets. Immediate accretion to core EPS/ROE implies durable earnings diversification and enhanced origination/distribution capabilities over the medium term.
Negative Factors
Adverse U.S. mortality driving earnings pressure
Significant unfavorable mortality in the U.S. indicates underlying underwriting and pricing risk that can persist beyond a single quarter. Such mortality shocks reduce core earnings, may require higher reserves or repricing, and can erode long-term profitability in a key developed-market franchise.
Elevated expected credit loss provisions on lower-grade loans
Charges tied to below-investment-grade loan exposure highlight credit risk in the investment portfolio and private lending exposure. Recurring or higher-than-expected ECLs would weigh on investment income and capital, increasing earnings volatility and potentially constraining growth investments or distributions.
Margin compression and inconsistent cash-flow conversion
Observed margin compression in 2025 and inconsistent cash-flow conversion reduce confidence in sustainable profitability. Volatile free cash flow and uneven coverage increase the risk of variability in dividends, capital deployment, and ability to fund acquisitions without relying on capital markets.

Manulife Financial (MFC) vs. iShares MSCI Canada ETF (EWC)

Manulife Financial Business Overview & Revenue Model

Company DescriptionManulife Financial Corporation, together with its subsidiaries, provides financial products and services in Asia, Canada, the United States, and internationally. The company operates through Wealth and Asset Management Businesses; Insurance and Annuity Products; And Corporate and Other segments. The Wealth and Asset Management Businesses segment provides mutual funds and exchange-traded funds, group retirement and savings products, and institutional asset management services through agents and brokers affiliated with the company, securities brokerage firms, and financial advisors pension plan consultants and banks. The Insurance and Annuity Products segment offers deposit and credit products; individual life, and individual and group long-term care insurance; and guaranteed and partially guaranteed annuity products through insurance agents, brokers, banks, financial planners, and direct marketing. The Corporate and Other segment is involved in property and casualty insurance and reinsurance businesses; and run-off reinsurance operations, including variable annuities, and accident and health. It also manages timberland and agricultural portfolios; and engages in insurance agency, portfolio and mutual fund management, mutual fund dealer, life, annuity, long-term care, and financial reinsurance; and fund management businesses. Additionally, the company holds and manages provides investment management, counseling, advisory, and dealer services. Manulife Financial Corporation was incorporated in 1887 and is headquartered in Toronto, Canada.
How the Company Makes MoneyManulife generates revenue through several key streams, primarily from premiums collected on insurance products, management fees from investment funds, and commissions from financial advisory services. The company's insurance segment earns income by underwriting life and health insurance policies, which involves assessing risk and collecting premiums over the policy's term. In its wealth and asset management divisions, Manulife earns management fees by overseeing investment portfolios and funds, which are charged as a percentage of the assets under management. Additionally, the company may receive performance fees tied to the success of certain investment products. Strategic partnerships with financial advisors and distribution networks enhance its ability to reach customers and drive sales growth. Furthermore, investment income derived from the company's own investment portfolio, which includes bonds, stocks, and real estate, contributes significantly to its overall earnings. Factors such as global economic conditions, interest rates, and demographic trends also influence its revenue generation.

Manulife Financial Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong growth in APE sales, positive net flows in Global WAM, and a strategic acquisition. However, it also noted challenges such as unfavorable U.S. mortality experience and elevated credit loss provisions. The sentiment is balanced with optimism for future growth and strategic alignment.
Q3-2025 Updates
Positive Updates
Strong Business Growth
APE sales increased 15% from the prior year with more than 30% growth in both Asia and the U.S. Strong sales supported significant growth in value metrics with 37% growth in new business CSM and 20% growth in new business value.
Positive Net Flows in Global WAM
Global WAM delivered positive net flows of nearly $1 billion, demonstrating the strength of its diversified platform.
Acquisition of Comvest Credit Partners
Manulife announced the acquisition of a 75% stake in Comvest Credit Partners for USD 937.5 million, expected to be immediately accretive to core EPS, core ROE, and core EBITDA margin.
Strong Capital Position
The LICAT capital ratio remained strong at 136% and the financial leverage ratio was 23.6%, continuing to stay well below the 25% medium-term target.
Continued Growth in Asia
Asia's APE increased 31% from the prior year, with substantial growth in Hong Kong, Mainland China, and Singapore.
Negative Updates
Unfavorable U.S. Mortality Experience
The U.S. segment's core earnings decreased by 53% from the prior year due to unfavorable mortality experience in the life business.
Elevated Expected Credit Loss Provision
The net investment result was impacted by a net charge in the expected credit loss provision, primarily related to certain below-investment-grade loan investments in the U.S.
Impact of eMPF Transition
The transition to the new eMPF platform in Hong Kong is expected to have a full quarterly run rate impact of approximately USD 25 million beginning in the first quarter of 2026.
Decline in U.S. Core Earnings
U.S. core earnings decreased due to unfavorable mortality experience, lower investment spreads, and strengthened ECL provisions.
Company Guidance
During the Manulife Financial second quarter 2025 earnings call, several key metrics and strategic updates were highlighted. The company announced its acquisition of a 75% stake in Comvest Credit Partners for USD 937.5 million, which is expected to be immediately accretive to core earnings per share (EPS), core return on equity (ROE), and core EBITDA margin. The acquisition will scale Manulife's private markets business, enhancing its private credit capabilities with Comvest's USD 14.7 billion platform. Manulife's LICAT ratio is expected to decrease by less than 3 percentage points due to the acquisition but remains strong at 136%. The second quarter results showed continued top-line growth, with insurance segments generating over 30% growth in new business contractual service margin (CSM) and 2% growth in core EPS from the previous year. However, profitability was affected by elevated U.S. mortality and a provision in expected credit loss, with core EPS growth normalizing to 7% when excluding the latter. The U.S. business saw a 40% increase in annual premium equivalent (APE) sales despite core earnings decreasing due to unfavorable mortality experience and lower investment spreads. Overall, Manulife remains confident in achieving its 2027 targets, including an 18%+ ROE, supported by strong underlying business growth and strategic capital deployment.

Manulife Financial Financial Statement Overview

Summary
Financials show a clear recovery after 2022: revenues rebounded, net margins normalized (~11–13% in 2023–2025), and leverage remains controlled (debt-to-equity ~0.20–0.29) with generally healthy ROE in normal years. Offsetting factors are 2025 margin compression and uneven cash-flow coverage signals, which point to potential earnings/cash-flow variability.
Income Statement
74
Positive
Revenue rebounded strongly after the 2022 downturn, accelerating in 2023 and remaining positive in 2024–2025. Profitability has normalized with solid net margins around ~11–13% in 2023–2025 versus a loss in 2022, and operating profitability is consistently positive again. The main weakness is margin compression in 2025 versus 2024 (gross and operating margins down), suggesting a less favorable mix or higher costs despite higher revenue.
Balance Sheet
78
Positive
Leverage looks controlled for the business, with debt-to-equity staying in a fairly tight band (~0.20–0.29) across the period, and equity remaining sizable. Returns on equity are consistently healthy in most years (roughly ~10–12%) with the notable exception of 2022, when losses drove returns negative. A watch item is the upward drift in leverage since 2021 and the very large asset base typical of insurers, which can amplify sensitivity to market and credit conditions.
Cash Flow
72
Positive
Cash generation is strong and improving: operating cash flow and free cash flow rise from 2022 through 2025, with 2025 delivering a step-up versus 2024. Free cash flow is shown equal to net income each year, indicating steady conversion on the provided data. The weakness is volatility and inconsistency in the cash-flow-to-profit relationship (including unusually high or zero coverage readings in some years), which reduces confidence in year-to-year cash flow quality based solely on these figures.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue53.01B45.58B42.31B23.62B59.84B
Gross Profit13.53B15.11B13.68B1.00B25.27B
EBITDA6.79B7.26B6.59B-3.56B9.66B
Net Income5.78B5.63B5.46B-2.10B6.66B
Balance Sheet
Total Assets1.03T978.82B875.57B848.94B917.64B
Cash, Cash Equivalents and Short-Term Investments36.33B25.79B20.34B19.15B22.59B
Total Debt14.68B14.16B12.74B12.36B11.86B
Total Liabilities972.95B925.86B826.85B792.56B858.77B
Stockholders Equity50.96B51.54B47.30B46.80B58.41B
Cash Flow
Free Cash Flow32.10B26.49B20.42B16.63B23.16B
Operating Cash Flow32.10B26.49B20.42B16.63B23.16B
Investing Cash Flow-28.36B-18.46B-13.72B-18.40B-24.44B
Financing Cash Flow-2.05B-4.17B-5.04B-1.83B-2.05B

Manulife Financial Technical Analysis

Technical Analysis Sentiment
Negative
Last Price48.57
Price Trends
50DMA
50.20
Negative
100DMA
48.24
Positive
200DMA
44.98
Positive
Market Momentum
MACD
-0.48
Positive
RSI
42.20
Neutral
STOCH
20.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MFC, the sentiment is Negative. The current price of 48.57 is below the 20-day moving average (MA) of 50.04, below the 50-day MA of 50.20, and above the 200-day MA of 44.98, indicating a neutral trend. The MACD of -0.48 indicates Positive momentum. The RSI at 42.20 is Neutral, neither overbought nor oversold. The STOCH value of 20.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MFC.

Manulife Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
C$54.78B7.5518.65%0.84%10.08%24.18%
76
Outperform
C$43.28B14.2213.24%3.28%-9.03%44.14%
74
Outperform
C$46.51B14.3216.27%1.86%2.51%44.44%
72
Outperform
C$49.39B14.5014.25%4.11%-19.88%-13.92%
69
Neutral
C$80.15B15.7511.14%3.49%5.46%10.52%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
65
Neutral
C$59.21B15.3815.09%3.62%-20.64%14.88%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:MFC
Manulife Financial
47.80
5.54
13.10%
TSE:SLF
Sun Life Financial
89.17
11.46
14.75%
TSE:FFH
Fairfax Financial Holdings
2,338.16
288.88
14.10%
TSE:GWO
Great-West Lifeco
65.50
13.99
27.15%
TSE:IFC
Intact Financial Corporation
261.96
-17.89
-6.39%
TSE:POW
Power Corp of Canada
68.28
20.66
43.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026